Market access is the fourth hurdle in the drug development process and the primary driver for global income of any new drug. Without a strategy in place for pricing, showing value for effectiveness and an understanding of the target purchasers’ needs, the drug will fail to reach its intended market value. Introduction to Market Access for Pharmaceuticals is based on an accredited course in this area, taken from the European Market Access University Diploma (EMAUD), and is affiliated with Aix Marseille University.

Key Features:

The first guide to market access for pharmaceuticals based on tested teaching materials
Addresses both pharmaceutical and vaccine products
Includes case studies and scenarios
Covers market access consdierations for Western Europe, the USA, Japan and China
Explains the impact the changing healthcare market will have on your product